This increase in the levels of proteolytic products of NCAM2 inversely correlates with the levels of full length NCAM2 at synapses, while the total levels of NCAM2 are also increased in AD hippocampus [59] (Figure 2). This evidence concerns the gene NCAM2 and Alzheimer disease.